How did the 2003 prescription drug re-importation bill pass the house?
| dc.contributor.author | Gokcekus, O | |
| dc.contributor.author | Adams, M | |
| dc.contributor.author | Grabowski, H | |
| dc.contributor.author | Tower, E | |
| dc.date.accessioned | 2013-04-23T17:01:34Z | |
| dc.date.issued | 2006-03-01 | |
| dc.description.abstract | We examine the major interest groups in the debate over allowing the re-importation of prescription drugs by utilizing a logit model and instrumental variables. Consistent with political support approach, the evidence suggests that Representatives are maximizing their electoral prospects: Contributions from pharmaceutical manufacturers shrink the probability of voting for the bill; and Representatives are sensitive to their constituencies - employees of pharmaceutical manufacturing and senior citizens. Representatives' gender and ideology regarding free trade and subsidies are also determining factors. However, the decision was, by and large, a partisan one: Party affiliation was the most important factor in passing the bill. © 2006 The Authors. Journal compilation © 2006 Blackwell Publishing Ltd. | |
| dc.identifier.eissn | 1468-0343 | |
| dc.identifier.issn | 0954-1985 | |
| dc.identifier.uri | ||
| dc.publisher | Wiley | |
| dc.relation.ispartof | Economics and Politics | |
| dc.relation.isversionof | 10.1111/j.1468-0343.2006.00161.x | |
| dc.title | How did the 2003 prescription drug re-importation bill pass the house? | |
| dc.type | Journal article | |
| pubs.begin-page | 27 | |
| pubs.end-page | 45 | |
| pubs.issue | 1 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Economics | |
| pubs.organisational-group | Trinity College of Arts & Sciences | |
| pubs.publication-status | Published | |
| pubs.volume | 18 |